Literature DB >> 34352287

Aging & COVID-19 susceptibility, disease severity, and clinical outcomes: The role of entangled risk factors.

Melina Farshbafnadi1, Sara Kamali Zonouzi2, Mohammadmahdi Sabahi3, Mahsa Dolatshahi4, Mohammad Hadi Aarabi5.   

Abstract

The emergence of Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) in late 2019 has been associated with a high rate of mortality and morbidity. It has been determined that the old population are not only at an increased risk for affliction with COVID-19 infection, but also atypical presentations, severe forms of the disease, and mortality are more common in this population. A plethora of mechanisms and risk factors contribute to the higher risk of infection in the old population. For instance, aging is associated with an increment in the expression of Angiotensin-Converting Enzyme-2 (ACE-2), the receptor for SARS-CoV-2 spike protein, which precipitates replication of the virus in the old population. On the other hand, immune dysregulation and changes in gut microbiota as a result of aging can contribute to the cytokine storm, one of the main indicators of disease severity. Decrement in sex steroids, especially in women, as well as growth hormone, both of which have crucial roles in immune regulation, is a key contributor to disease severity in old age. Senescence-associated oxidative stress and mitochondrial dysfunction in both pneumocytes and immune cells contribute to the severity of infection in an exacerbative manner. In addition, lifestyle-associated factors such as nutrition and physical activity, which are compromised in old age, are known as important factors in COVID-19 infection. Aging-associated comorbidities, especially cardiovascular diseases and Diabetes Mellitus, also put older adults at an increased risk of complications, and disease severity.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  ARDS; Mortality; Older adults; SARS-CoV-2

Year:  2021        PMID: 34352287     DOI: 10.1016/j.exger.2021.111507

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  16 in total

1.  The Impact of Age and Gender and Their Association with Chemosensory Dysfunction, in Hospitalized and Self-Quarantine Patients with Covid-19 Infection, in Epirus, Greece.

Authors:  Athina Zarachi; Vasileios Pezoulas; Orestis Milionis; Aikaterini N Lianou; Eleutherios Klouras; Ioannis Komnos; Dimitrios Fotiadis; Ioannis Kastanioudakis; Charalampos Milionis; Angelos Liontos
Journal:  Maedica (Bucur)       Date:  2022-03

2.  Clinical Characteristics and Predictors of Mortality in Elderly Patients Hospitalized with COVID-19 in Bangladesh: A Multicenter, Retrospective Study.

Authors:  Md Asaduzzaman; Z H M Nazmul Alam; Mohammad Zabed Jillul Bari; M M Jahangir Alam; Shishir Ranjan Chakraborty; Tasnim Ferdousi
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-06-11

3.  Bacterial and Fungal Co-Infections and Superinfections in a Cohort of COVID-19 Patients: Real-Life Data from an Italian Third Level Hospital.

Authors:  Manuela Ceccarelli; Andrea Marino; Sarah Pulvirenti; Viviana Coco; Barbara Busà; Giuseppe Nunnari; Bruno Santi Cacopardo
Journal:  Infect Dis Rep       Date:  2022-05-12

4.  Oral dysbiosis and its linkage with SARS-CoV-2 infection.

Authors:  Abhishek Gupta; Shivang Bhanushali; Avinash Sanap; Madhura Shekatkar; Avinash Kharat; Chandrashekhar Raut; Ramesh Bhonde; Yogesh Shouche; Supriya Kheur; Avinash Sharma
Journal:  Microbiol Res       Date:  2022-05-04       Impact factor: 5.070

5.  CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells.

Authors:  Virginia Lotti; Flavia Merigo; Anna Lagni; Andrea Di Clemente; Marco Ligozzi; Paolo Bernardi; Giada Rossini; Ercole Concia; Roberto Plebani; Mario Romano; Andrea Sbarbati; Claudio Sorio; Davide Gibellini
Journal:  Cells       Date:  2022-04-15       Impact factor: 6.600

6.  Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients.

Authors:  Zainab S Mahmood; Hula Y Fadhil; Thaer A Abdul Hussein; Ali H Ad'hiah
Journal:  Meta Gene       Date:  2022-01-10

Review 7.  Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities.

Authors:  Modjtaba Emadi-Baygi; Mahsa Ehsanifard; Najmeh Afrashtehpour; Mahnaz Norouzi; Zahra Joz-Abbasalian
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

Review 8.  Immunosenescence and COVID-19.

Authors:  Jacek M Witkowski; Tamas Fulop; Ewa Bryl
Journal:  Mech Ageing Dev       Date:  2022-04-01       Impact factor: 5.498

9.  Prognostic Factors for COVID-19 Hospitalized Patients with Preexisting Type 2 Diabetes.

Authors:  Yuanyuan Fu; Ling Hu; Hong-Wei Ren; Yi Zuo; Shaoqiu Chen; Qiu-Shi Zhang; Chen Shao; Yao Ma; Lin Wu; Jun-Jie Hao; Chuan-Zhen Wang; Zhanwei Wang; Richard Yanagihara; Youping Deng
Journal:  Int J Endocrinol       Date:  2022-01-17       Impact factor: 2.803

10.  SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Promote a Proinflammatory Activation Profile on Human Dendritic Cells.

Authors:  Dante Barreda; César Santiago; Juan R Rodríguez; José F Rodríguez; José M Casasnovas; Isabel Mérida; Antonia Ávila-Flores
Journal:  Cells       Date:  2021-11-23       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.